Francisco Partners to Acquire IBM Watson Health Data Assets
IBM sells its healthcare data and analytics assets from the Watson Health division to investment firm Francisco Partners. The deal allows IBM to focus on its hybrid cloud and AI strategy while the acquired assets form a new standalone company.
IBM and Francisco Partners sign a definitive agreement for the investment firm to acquire healthcare data and analytics assets from the Watson Health business. The acquired assets include extensive data sets and popular products such as Health Insights, MarketScan, Clinical Development, Micromedex, and various imaging software offerings. The transaction is expected to close in the second quarter of the year, pending customary regulatory clearances, though financial terms remain undisclosed.
This acquisition allows IBM to become even more focused on its platform-based hybrid cloud and AI strategy. IBM remains committed to its broader AI business and continues to support clients and partners in the healthcare IT sector. Meanwhile, Francisco Partners takes control of data and analytics assets that benefit from the enhanced investment and specialized expertise of a healthcare-focused portfolio.
Francisco Partners brings extensive experience in healthcare technology to the table, with a history of investing in companies that leverage technology to provide innovative solutions to the entire healthcare ecosystem. The firm expresses deep appreciation for the market-leading team and mission-critical products IBM built over the years. Under Francisco Partners, these acquired healthcare assets are positioned to enter their next phase of growth as a new standalone company.